Bayer AG (BAYRY) is considering selling its diabetes device business, which could fetch the Germany company up to EUR2 billion, Bloomberg News reported Monday on its website, citing people with knowledge of the matter.

Bayer, which has hired Credit Suisse Group AG (CS) to assist with the process, also plans to list its plastics unit on the stock market, Bloomberg reported.

Full story at: www.businessweek.com/news/2014-11-24/bayer-said-to-explore-sale-of-2-dot-5-billion-diabetes-unit

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Credit Suisse (NYSE:CS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Credit Suisse Charts.
Credit Suisse (NYSE:CS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Credit Suisse Charts.